These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27249754)

  • 1. Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit?
    Iyengar P; Lau S; Donington JS; Suh RD
    Am Soc Clin Oncol Educ Book; 2016; 35():e460-7. PubMed ID: 27249754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.
    Yano T; Okamoto T; Haro A; Fukuyama S; Yoshida T; Kohno M; Maehara Y
    Lung Cancer; 2013 Dec; 82(3):431-5. PubMed ID: 24113550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer.
    Yano T; Haro A; Yoshida T; Morodomi Y; Ito K; Shikada Y; Shoji F; Maruyama R; Maehara Y
    J Surg Oncol; 2010 Dec; 102(7):852-5. PubMed ID: 20886558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
    Hasselle MD; Haraf DJ; Rusthoven KE; Golden DW; Salgia R; Villaflor VM; Shah N; Hoffman PC; Chmura SJ; Connell PP; Vokes EE; Weichselbaum RR; Salama JK
    J Thorac Oncol; 2012 Feb; 7(2):376-81. PubMed ID: 22198429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer: Theory and Practice.
    Rusthoven CG; Yeh N; Gaspar LE
    Cancer J; 2015; 21(5):404-12. PubMed ID: 26389766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer.
    Westover KD; Iyengar P; Sharma AN; Timmerman R
    Lung Cancer; 2015 Aug; 89(2):87-93. PubMed ID: 26028304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SABR vs surgery for NSCLC in the media.
    Rice D; Sepesi B; Heymach J; Swisher S; Vaporciyan A
    Lancet Oncol; 2015 Sep; 16(9):e422. PubMed ID: 26370343
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.
    Guerrero E; Ahmed M
    Lung Cancer; 2016 Feb; 92():22-8. PubMed ID: 26775592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery versus SABR for resectable non-small-cell lung cancer.
    Hamaji M; Groth SS; Sugarbaker DJ; Burt BM
    Lancet Oncol; 2015 Aug; 16(8):e372. PubMed ID: 26248839
    [No Abstract]   [Full Text] [Related]  

  • 11. Surgery versus SABR for resectable non-small-cell lung cancer.
    Opitz I; Rocco G; Brunelli A; Varela G; Massard G; Weder W;
    Lancet Oncol; 2015 Aug; 16(8):e372-3. PubMed ID: 26248838
    [No Abstract]   [Full Text] [Related]  

  • 12. Surgery versus SABR for resectable non-small-cell lung cancer.
    Zhang L; Tian J; Wang C
    Lancet Oncol; 2015 Aug; 16(8):e371-2. PubMed ID: 26248837
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgery versus SABR for resectable non-small-cell lung cancer.
    Cao C; D'Amico T; Demmy T; Dunning J; Gossot D; Hansen H; He J; Jheon S; Petersen RH; Sihoe A; Swanson S; Walker W; Yan TD;
    Lancet Oncol; 2015 Aug; 16(8):e370-1. PubMed ID: 26248836
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer.
    Katz MS; Husain ZA
    Lancet Oncol; 2016 Feb; 17(2):e41-e42. PubMed ID: 26868347
    [No Abstract]   [Full Text] [Related]  

  • 15. Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation.
    Nieder C; De Ruysscher D; Gaspar LE; Guckenberger M; Mehta MP; Cheung P; Sahgal A
    Strahlenther Onkol; 2017 Jul; 193(7):515-524. PubMed ID: 28424839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.
    Chang JY; Senan S; Smit EF; Roth JA
    Lancet Oncol; 2015 Aug; 16(8):e374-5. PubMed ID: 26248841
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer - Authors' reply.
    Chang JY; Senan S; Smit EF; Roth JA
    Lancet Oncol; 2016 Feb; 17(2):e42-e43. PubMed ID: 26868349
    [No Abstract]   [Full Text] [Related]  

  • 18. [Randomised comparison of stereotactic body radiotherapy versus lobectomy in stage I NSCLC--level I evidence at last?].
    Guckenberger M; Andratschke N
    Strahlenther Onkol; 2015 Dec; 191(12):988-90. PubMed ID: 26459463
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances in radiotherapy for lung cancer.
    Decker RH; Wilson LD
    Semin Respir Crit Care Med; 2008 Jun; 29(3):285-90. PubMed ID: 18506666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
    Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
    Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.